DFX Intelligence

Data Factory

VentureFirminstitutional vc · probableregistered_investment_adviser

Sofinnova Investments, Inc.

Venture Capital

Menlo Park, CA

Sofinnova deploys human and financial capital to turn dreams into drugs. We are a clinical-stage biopharmaceutical venture capital firm with approximately $2B in assets under management and committed capital.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:058a7efd-539a-4af8-aad4-72410c378806

Data as of Sep 17, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 20, 2026, 10:10 AM UTC and rebuilt at most every 15 minutes.

Relationships: 133
Dated events: 40
On other graphs: 2
Observed: Sep 12, 2026 to Sep 17, 2026
68 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

RIA / Wealth Managementidentity

SOFINNOVA INVESTMENTS, INC.

Registered adviser · cited, shared crd

Allocatorsidentity

Sofinnova Investments, Inc.

Manager with allocator commitments · cited, shared crd

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Funds: 12
Vintages: 2011 to 2021
Reported GAV: $1.3Bgross asset value on Form ADV; never dry powder
Regulatory AUM: $5.4B
Funds with fundraising evidence: 0derived
Investments: 60
Portfolio companies: 60
Investments, 12m: 60
Partner-attributed: 2
People: 54
Investment professionals: 31derived
Co-investors: 0derived
LP relationships: 1
Stated sectors: biotechas stated by the firm
Stated geography: boston,new york
Latest Form D: Sep 11, 2023
Latest ADV filing: Mar 27, 2026
Website: sofinnova.com

Funds

Fund	Vintage	Lifecycle	Form D sold	GAV
Sofinnova Venture Partners Xi, L.P.	2021	Mature	$500M	$236M
Sofinnova Venture Partners X, L.P.	2016	Harvest	$596M	$803M
Sofinnova Venture Partners Ix, L.P.	2015	Harvest	$0	$289M
80	2014	Wound down	n/a	$2.2M
Sofinnova Venture Partners Viii, L.P.	2011	Harvest	$440M	$7.7M
155	n/a	Wound down	n/a	$0
94	n/a	Wound down	n/a	$28,731
Sofinnova Venture Partners VII, L.P.	n/a	Wound down	n/a	$150M
Sofinnova Venture Affiliates VI, L.P.	n/a	Wound down	n/a	$0
Sofinnova Venture Partners VI, L.P.	n/a	Wound down	n/a	$0
294	n/a	Wound down	n/a	$191,747
194	n/a	Wound down	n/a	$3,159

Investments

round size is never this investor's check

Company	State	Stage	Round size	Partner	Attribution	Observed
Aeovian	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
merus.nl	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Inozyme	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026
Cincor	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026
Serestherapeutics	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026
Xylocor	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026
Neuranapharma	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026
Atyrpharma	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026
Medeortherapeutics	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026
Incardatherapeutics	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026
Sophirisbio	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026
Edgetherapeutics	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026
Dauntlessph	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026
Chiasmapharma	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026
Checkmatepharma	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026
Kiniksa	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026
Ascendispharma	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026
Apellis	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026
Antivabio	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026
Zspharma	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026
Versartis	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026
Tesarobio	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026
Coultreon	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026
Sarcode	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026
Investor Portal	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026

Co-investors

pairs come only from shared rounds and listings

Investor	Co-investor	Shared deals	Shared companies	Last observed	Strength
Sofinnova Investments, Inc.	Avoro Capital Advisors LLC	7	7	Sep 16, 2026	Strong
Sofinnova Investments, Inc.	Omega Fund Management, LLC	3	3	Sep 13, 2026	Recurring
Sofinnova Investments, Inc.	Sofinnova Partners	2	2	Sep 16, 2026	Recurring
Sofinnova Investments, Inc.	Samsara Biocapital, LLC	2	2	Sep 12, 2026	Recurring
Sofinnova Investments, Inc.	Carnelian Energy Capital Management, LP	1	1	Sep 12, 2026	One time
Sofinnova Investments, Inc.	Plural Uk Management	1	1	Sep 12, 2026	One time
Sofinnova Investments, Inc.	4x4 Capital	1	1	Sep 12, 2026	One time
Sofinnova Investments, Inc.	Mcwhorter Ventures, LLC	1	1	Sep 12, 2026	One time
Sofinnova Investments, Inc.	Rice Park Capital	1	1	Sep 12, 2026	One time
Sofinnova Investments, Inc.	5th Century Partners	1	1	Sep 12, 2026	One time
Sofinnova Investments, Inc.	DN Capital (US), Inc	1	1	Sep 12, 2026	One time
Sofinnova Investments, Inc.	Galapagos	1	1	Apr 28, 2026	One time
Sofinnova Investments, Inc.	Balyasny Asset Management L.P.	1	1	Apr 28, 2026	One time
Sofinnova Investments, Inc.	Regeneron Ventures	1	1	Apr 28, 2026	One time
Sofinnova Investments, Inc.	Unless Management LP	1	1	Sep 12, 2026	One time

Relationships

showing 80 of 133

Invested in (23)

→ AeovianCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ merus.nlCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Quanta Therapeutics, Inc.CompanyBoard only
Jun 24, 2026 to presentinferenceForm D
→ Coultreon BiopharmaCompanyround
Apr 28, 2026 to presentfactNews and newswire
→ PharmasonicsCompanyPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site
→ ObsEvaCompanyPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site
→ NextCure, Inc.CompanyPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site
→ Investor PortalCompanyPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site
→ CoultreonCompanyPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site
→ CincorCompanyPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site
→ InozymeCompanyPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site
→ XylocorCompanyPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site
→ KiniksaCompanyPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site
→ NeuranapharmaCompanyPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site
→ MedeortherapeuticsCompanyPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site
→ IncardatherapeuticsCompanyPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site
→ SerestherapeuticsCompanyPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site
→ OrexigenCompanyPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site
→ MallinckrodtCompanyPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site
→ NextwavepharmaCompanyPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site
→ MarinuspharmaCompanyPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site
→ CatalystbiosciencesCompanyPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site
→ AntheraCompanyPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site

Employs (45)

→ Alex DulnevPersonIT Manager
factThe subject's own site
→ Gina BakerPerson& Operations Manager, Public Equity
factThe subject's own site
→ Katrin VillerPersonVice President Finance, Private Equity
factThe subject's own site
→ Kathy DuPersonVice President of Finance, Public Equity
factThe subject's own site
→ Smita ChowdhriPersonController, Public Equity
factThe subject's own site
→ Alex ChanPersonController, Private Equity
factThe subject's own site
→ Surin KimPersonFinancial Analyst, Private Equity
factThe subject's own site
→ Tiffany DavisPersonDirector of IR and Marketing,
factThe subject's own site
→ Lesley WeberPersonExecutive Assistant
factThe subject's own site
→ Jenn SymmonsPersonEvents Manager
factThe subject's own site
→ Josie KastelicPersonMenlo Park Office Manager
factThe subject's own site
→ Dina HauserPersonExecutive Assistant
factThe subject's own site
→ Amanda PhillipsPersonExecutive Assistant
factThe subject's own site
→ Laurel RussellPersonNew York Office Manager
factThe subject's own site
→ Maha KatabiPersonGeneral Partner
factThe subject's own site, News and newswire
→ Troy IgnelziPersonExecutive Advisor, Private Equity
factThe subject's own site
→ Kasey OlsonPersonBoston Office Manager
factThe subject's own site
→ Jim HealyPersonManaging Partner
factThe subject's own site
→ Jonathan LeffPersonExecutive Partner, Private Equity
factThe subject's own site
→ Chris CarpenterPersonExecutive Partner, Private Equity
factThe subject's own site
→ Jakob DupontPersonExecutive Partner, Private Equity
factThe subject's own site
→ Maha RadhakrishnanPersonExecutive Partner, Private Equity
factThe subject's own site
→ Merdad ParseyPersonExecutive Partner, Private Equity
factThe subject's own site
→ Ricardo Grieshaber-BouyerPersonVenture Partner, Private Equity
factThe subject's own site
→ Lars EkmanPersonExecutive Partner, Private Equity
factThe subject's own site
→ David KabakoffPersonExecutive Advisor, Private Equity
factThe subject's own site
→ Perry NisenPersonExecutive Advisor, Private Equity
factThe subject's own site
→ Mike VanPersonAssociate, Private Equity
factThe subject's own site
→ Naomi PacalinPersonAssociate, Private Equity
factThe subject's own site
→ Eric HsuPersonAnalyst, Private Equity
factThe subject's own site
and 15 more

Manages (10)

→ 80FundVenture Capital Fund
Mar 27, 2014 to presentfactForm ADV
→ Sofinnova Venture Partners VII, L.P.FundVenture Capital Fund
Mar 30, 2012 to presentfactForm ADV
→ Sofinnova Venture Partners X, L.P.FundVenture Capital Fund
Mar 3, 2017 to presentfactForm ADV
→ Sofinnova Venture Partners Viii, L.P.FundVenture Capital Fund
Mar 30, 2012 to presentfactForm ADV
→ Sofinnova Venture Partners VI, L.P.FundVenture Capital Fund
Mar 30, 2012 to presentfactForm ADV
→ Sofinnova Venture Affiliates VI, L.P.FundVenture Capital Fund
Mar 30, 2012 to presentfactForm ADV
→ 194FundVenture Capital Fund
Mar 30, 2012 to presentfactForm ADV
→ Sofinnova Venture Partners Ix, L.P.FundVenture Capital Fund
Mar 27, 2015 to presentfactForm ADV
→ 94FundVenture Capital Fund
Mar 30, 2012 to presentfactForm ADV
→ 294FundVenture Capital Fund
Mar 30, 2012 to presentfactForm ADV

Lp of (1)

← Massachusetts Pension Reserves Investment Management BoardLimited partnerprimary
factPlan disclosure

Dated events

40 bookkeeping events (roster, classification and holdings changes) folded below

Show 40 bookkeeping events

First seen by DFX
Sep 16, 2026
date not stated
Versartis no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Zspharma no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Atyrpharma no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Checkmatepharma no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Ascendispharma no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Antivabio no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Chiasmapharma no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Edgetherapeutics no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Inozyme no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Kiniksa no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Incardatherapeutics no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Xylocor no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Medeortherapeutics no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Apellis no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Dauntlessph no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Serestherapeutics no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Neuranapharma no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Aeriepharma no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
PregLem no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Orexigen no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Mallinckrodt no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Nextwavepharma no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Marinuspharma no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Catalystbiosciences no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Anthera no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Alvinepharma no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Mtem no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Tensysmedical no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Humanigen no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Actelion no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Anesiva no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Seattlegenetics no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Pharmasonics no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Intermune no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Entelos no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
NextCure, Inc. no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
ObsEva no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Coultreon no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Cincor no longer listed on Sofinnova Investments, Inc.'s portfolio page
First seen by DFX
Sep 16, 2026
date not stated
Tesarobio no longer listed on Sofinnova Investments, Inc.'s portfolio page

Who to call

the organisation, the role and the published line, with the filing or website that published it; revealed to signed-in accounts

The firm's published line

Revealable: 1 business phone (Form ADV), 1 website (Form ADV), 3 work emails (firm website) · as of 2026-09-16

Also named here, with no published line of their own (reach them through the firm): Alex Dulnev (IT Manager), Gina Baker (& Operations Manager, Public Equity), Katrin Viller (Vice President Finance, Private Equity), Kathy Du (Vice President of Finance, Public Equity), Smita Chowdhri (Controller, Public Equity), Alex Chan (Controller, Private Equity), Surin Kim (Financial Analyst, Private Equity), Tiffany Davis (Director of IR and Marketing,), Lesley Weber (Executive Assistant), Jenn Symmons (Events Manager), Josie Kastelic (Menlo Park Office Manager), Dina Hauser (Executive Assistant).

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Provenance

Graph: Venture Capital
Canonical id: dfx:vc:058a7efd-539a-4af8-aad4-72410c378806
First observed: Sep 12, 2026
Last observed: Sep 17, 2026 3 days ago
Source families: Federal regulator filings, Firm and issuer disclosures
3 registered feeds stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Sofinnova Investments, Inc.

Venture Capital

Menlo Park, CA

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:058a7efd-539a-4af8-aad4-72410c378806

Data as of Sep 17, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 20, 2026, 10:10 AM UTC and rebuilt at most every 15 minutes.

Fund

Vintage

Lifecycle

Form D sold

GAV

LPs

Sofinnova Venture Partners Xi, L.P.

2021

Mature

$500M

$236M

Sofinnova Venture Partners X, L.P.

2016

Harvest

$596M

$803M

Sofinnova Venture Partners Ix, L.P.

2015

Harvest

$289M

2014

Wound down

n/a

$2.2M

Sofinnova Venture Partners Viii, L.P.

2011

Harvest

$440M

$7.7M

155

n/a

Wound down

n/a

Wound down

n/a

$28,731

Sofinnova Venture Partners VII, L.P.

n/a

Wound down

n/a

$150M

Sofinnova Venture Affiliates VI, L.P.

n/a

Wound down

n/a

Sofinnova Venture Partners VI, L.P.

n/a

Wound down

n/a

294

n/a

Wound down

n/a

$191,747

194

n/a

Wound down

n/a

$3,159

Company

State

Stage

Round size

Partner

Attribution

Observed

Aeovian

n/a

Unknown

Sep 16, 2026

merus.nl

n/a

Unknown

Sep 16, 2026

Inozyme

n/a

Unknown

Sep 12, 2026

Cincor

n/a

Unknown

Sep 12, 2026

Serestherapeutics

n/a

Unknown

Sep 12, 2026

Xylocor

n/a

Unknown

Sep 12, 2026

Neuranapharma

n/a

Unknown

Sep 12, 2026

Atyrpharma

n/a

Unknown

Sep 12, 2026

Medeortherapeutics

n/a

Unknown

Sep 12, 2026

Incardatherapeutics

n/a

Unknown

Sep 12, 2026

Sophirisbio

n/a

Unknown

Sep 12, 2026

Edgetherapeutics

n/a

Unknown

Sep 12, 2026

Dauntlessph

n/a

Unknown

Sep 12, 2026

Chiasmapharma

n/a

Unknown

Sep 12, 2026

Checkmatepharma

n/a

Unknown

Sep 12, 2026

Kiniksa

n/a

Unknown

Sep 12, 2026

Ascendispharma

n/a

Unknown

Sep 12, 2026

Apellis

n/a

Unknown

Sep 12, 2026

Antivabio

n/a

Unknown

Sep 12, 2026

Zspharma

n/a

Unknown

Sep 12, 2026

Versartis

n/a

Unknown

Sep 12, 2026

Tesarobio

n/a

Unknown

Sep 12, 2026

Coultreon

n/a

Unknown

Sep 12, 2026

Sarcode

n/a

Unknown

Sep 12, 2026

Investor Portal

n/a

Unknown

Sep 12, 2026

Investor

Co-investor

Shared deals

Shared companies

Last observed

Strength

Sofinnova Investments, Inc.

Avoro Capital Advisors LLC

Sep 16, 2026

Strong

Sofinnova Investments, Inc.

Omega Fund Management, LLC

Sep 13, 2026

Recurring

Sofinnova Investments, Inc.

Sofinnova Partners

Sep 16, 2026

Recurring

Sofinnova Investments, Inc.

Samsara Biocapital, LLC

Sep 12, 2026

Recurring

Sofinnova Investments, Inc.

Carnelian Energy Capital Management, LP

Sep 12, 2026

One time

Sofinnova Investments, Inc.

Plural Uk Management

Sep 12, 2026

One time

Sofinnova Investments, Inc.

4x4 Capital

Sep 12, 2026

One time

Sofinnova Investments, Inc.

Mcwhorter Ventures, LLC

Sep 12, 2026

One time

Sofinnova Investments, Inc.

Rice Park Capital

Sep 12, 2026

One time

Sofinnova Investments, Inc.

5th Century Partners

Sep 12, 2026

One time

Sofinnova Investments, Inc.

DN Capital (US), Inc

Sep 12, 2026

One time

Sofinnova Investments, Inc.

Galapagos

Apr 28, 2026

One time

Sofinnova Investments, Inc.

Balyasny Asset Management L.P.

Apr 28, 2026

One time

Sofinnova Investments, Inc.

Regeneron Ventures

Apr 28, 2026

One time

Sofinnova Investments, Inc.

Unless Management LP

Sep 12, 2026

One time